Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Fiboresp Tablet

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Pirfenidone (200mg)

Overview Fiboresp Tablet

Pirfenidone tablets are a prescription medication indicated for idiopathic pulmonary fibrosis. This treatment lessens lung inflammation and fibrosis, improving breathing capacity. For optimal absorption, consume Pirfenidone with food, consistently at the same time daily. Dosage frequency and amount are determined by your physician based on individual needs and response. Continue taking this medication as directed by your doctor. Common side effects include sleep disturbances, headaches, vertigo, indigestion, nausea, loose stools, and sun sensitivity. To mitigate dizziness, refrain from driving or activities requiring focus. Weight loss is a possibility; regular monitoring is advisable, consult your doctor if concerning changes occur. Liver function tests may be conducted during treatment. Inform your physician of any pre-existing liver or kidney conditions, and all other medications you're using, as interactions may affect Pirfenidone's efficacy. Due to increased sun sensitivity, utilize protective clothing and sunscreen during sun exposure. Disclose pregnancy or breastfeeding to your doctor before commencing treatment.

Primary Ingredients of Fiboresp Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Fiboresp Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Fiboresp Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Fiboresp Tablet with a meal.

Common Side effects of Fiboresp Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Fiboresp Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Fiboresp Tablet with a meal.

How Fiboresp Tablet works:

Fiboresp tablets offer antifibrotic therapy by inhibiting a specific endogenous compound implicated in fibrotic processes. This mechanism diminishes pulmonary scarring and inflammation, thereby improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Fiboresp Tablet lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Fiboresp Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Fiboresp Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Fiboresp Tablets may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Fiboresp Tablets, as dose modification may be necessary. Severe kidney disease and those undergoing dialysis should not use Fiboresp Tablets; consult a physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Fiboresp Tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Fiboresp Tablet use; consult a physician before administration.

What if you forget to take Fiboresp Tablet :

NA

Facts to Know About Fiboresp Tablet

LabelValue
Chemical Category Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Actions Pulmonary fibrosis of unknown cause

FAQs on Fiboresp Tablet

Before starting Fiboresp Tablet treatment, your doctor will assess your liver function. This will be monitored monthly for six months, then every three months thereafter. Your lung function will also be periodically assessed to track your response to the medication.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, consistent use of Fiboresp Tablets, as directed by your physician, is strongly advised to help maintain your current lung capacity.
Fiboresp Tablet may cause common side effects such as sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other common side effects include upper respiratory and urinary tract infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, dyspnea, and cough. Gastrointestinal issues like acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions such as itching, redness, dryness, and rash are possible, along with muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Fiboresp Tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, hindering breathing. Fiboresp helps alleviate these effects, improving respiratory function.
You and your doctor should determine if Fiboresp Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your treatment response and tolerance.
Idiopathic pulmonary fibrosis progresses unpredictably. Always consult your doctor before stopping Fiboresp Tablet, which helps slow disease progression.
Minimize sun exposure while using Fiboresp Tablets. Daily sunscreen application and protective clothing (covering arms, legs, and head) are recommended. Additionally, avoid smoking to maximize the tablet's effectiveness.
While the average lifespan for pulmonary fibrosis patients is two to three years, some individuals survive significantly longer. Reduced survival is linked to older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally) and the onset of additional lung issues.
Fiboresp Tablet
226
MRP 261
13% off